Decision: Favourable
Study Title:
A multicenter, open-label extension study to investigate the long-term safety of FAB122 in patients with Amyotrophic Lateral Sclerosis ADOREXT (ALS trial with Daily ORal Edaravone EXTension) study
NREC Code:
23-NREC-CT-008
Decision:
Favourable
Meeting Date:
25/01/2023
Study Type:
CT application
Principal Investigator:
Prof Orla Hardiman
PI Institution:
Beaumont Hospital
Sponsor:
Ferrer Internacional, S.A